๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II Clinical Trial of Recombinant alpha-2 Interferon for Biopsy-proven Metastatic or Recurrent Renal Carcinoma

โœ Scribed by M. A. ROSENTHAL; K. COX; D. RAGHAVAN; J. J. GRYGIEL; R. D. WINES; H. MAMEGHAN; J. ROGERS

Book ID
115196789
Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
298 KB
Volume
69
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A Phase II trial of 5-fluorouracil and r
A Phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma
โœ Richard Pazdur; Jaffer A. Ajani; Rodger Winn; James Bearden; Robert J. Belt; Sus ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 468 KB ๐Ÿ‘ 3 views

A Phase I1 clinical trial of the combination of 5-fluorouracil (5-FU) and recombinant alpha-2a-interferon (a-2a-IFN) was conducted in 44 patients. Patients had not received chemotherapy previously and had measurable metastatic gastric carcinoma. 5-FU was administered as a continuous infusion at a do

Phase II clinical trial with 5-fluoroura
Phase II clinical trial with 5-fluorouracil, recombinant interferon-ฮฑ-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus
โœ Scott Wadler; Hilda Haynes; Jonathan J. Beitler; Xiaoping Hu; Stanley Fell; Marg ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 393 KB ๐Ÿ‘ 1 views

## Background: Recombinant interferon-alpha (ifn) augments the cytotoxicity of both 5-fluorouracil (5-fu) and cisplatin in vitro. a phase ii study of 5-fu and ifn resulted in response rates of 25-27% in patients with metastatic esophageal carcinoma. ## Methods: A phase ii trial was initiated to d